Publications

Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.

GOSLING, RD; Gesase, S; Mosha, JF; CARNEIRO, I; Hashim, R; Lemnge, M; Mosha, FW; GREENWOOD, B; CHANDRAMOHAN, D;

2009

Lancet, (2009).374 9700 10.1016/S0140-6736(09)60997-1.

Effect of two different house screening interventions on exposure to malaria vectors and on anaemia in children in The Gambia: a randomised controlled trial.

KIRBY, MJ; Ameh, D; BOTTOMLEY, C; Green, C; Jawara, M; MILLIGAN, PJ; SNELL, PC; CONWAY, DJ; Lindsay, SW;

2009

Lancet, (2009).374 9694 10.1016/S0140-6736(09)60871-0.

Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania.

Sabot, OJ; Mwita, A; Cohen, JM; Ipuge, Y; Gordon, M; Bishop, D; Odhiambo, M; Ward, L; GOODMAN, C;

2009

PloS one, (2009).4 9 10.1371/journal.pone.0006857.

Knowledge and practices for preventing severe malaria in Yemen: the importance of gender in planning policy.

Al-Taiar, A; CHANDLER, C; Al Eryani, S; WHITTY, CJ M;

2009

Health policy and planning, (2009).24 6 10.1093/heapol/czp034.

Combining indoor residual spraying and insecticide-treated net interventions.

KLEINSCHMIDT, I; Schwabe, C; Shiva, M; Segura, JL; Sima, V; Mabunda, SJ A; Coleman, M;

2009

The American journal of tropical medicine and hygiene, (2009).81 3 10.4269/ajtmh.2009.81.519.

Do we still need a malaria vaccine?.

GREENWOOD, B; TARGETT, G;

2009

Parasite immunology, (2009).31 9 10.1111/j.1365-3024.2009.01140.x.

Signalling in malaria parasites. The MALSIG consortium.

Doerig, C; BAKER, D; Billker, O; BLACKMAN, MJ; Chitnis, C; Dhar Kumar, S; Heussler, V; Holder, AA; Kocken, C; Krishna, S; Langsley, G; Lasonder, E; Menard, R; Meissner, M; Pradel, G; Ranford-Cartwright, L; Sharma, A; Sharma, P; Tardieux, T; Tatu, U; Alano, P;

2009

Parasite (Paris, France), (2009).16 3 10.1051/parasite/2009163169.

Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, Angola.

Menegon, M; Pearce, RJ; Inojosa, WO; Pisani, V; Abel, PM; Matondo, A; Bisoffi, Z; Majori, G; Ord, R; WARHURST, DC; ROPER, C; Severini, C;

2009

Tropical medicine & international health, (2009).14 10 10.1111/j.1365-3156.2009.02369.x.

Human helminth co-infection: no evidence of common genetic control of hookworm and Schistosoma mansoni infection intensity in a Brazilian community.

PULLAN, RL; Bethony, JM; Geiger, SM; Correa-Oliveira, R; BROOKER, S; Quinnell, RJ;

2009

International journal for parasitology, (2009).40 3 10.1016/j.ijpara.2009.08.002.

Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria.

Premji, Z; Umeh, RE; OWUSU-AGYEI, S; Esamai, F; Ezedinachi, EU; Oguche, S; Borrmann, S; Sowunmi, A; Duparc, S; Kirby, PL; Pamba, A; Kellam, L; Guiguemdé, R; GREENWOOD, B; Ward, SA; Winstanley, PA;

2009

PloS one, (2009).4 8 10.1371/journal.pone.0006682.